The primary objective of this study is to characterize cerebral metabolism modifications using 18F-FDG PET technology and perfusion with 99MTC-ECD SPECT in patients with prodromal Alzheimer's Disease drawn from a high risk population. We also compare PET and SPECT imaging within this framework, and search for optimal diagnostic thresholds.
Study Type
OBSERVATIONAL
Enrollment
143
CHU d'Amiens - Hôpital Sud
Amiens, France
The difference between AUCs for PET and SPECT imaging
The difference between the AUCs (area under the curve) for PET and SPECT imaging.
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU d'Angers - Hôtel-Dieu
Angers, France
CHU de Besançon - Hôpital Jean Minjoz
Besançon, France
CHU de Bordeaux - Groupe Hospitalier Pellegrin
Bordeaux, France
APHP - Hôpital Albert Chenevier
Créteil, France
APHP - Hôpital Charles Foix
Ivry-sur-Seine, France
CHRU de Lille - Hôpital Claude Huriez
Lille, France
CHRU de Lille - Hôpital Roger Salengro
Lille, France
APHP - Hôpital Emile Roux
Limeil-Brévannes, France
APHM - Hôpital La Timone Adultes
Marseille, France
...and 15 more locations